Clinical Trial Update: A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing 5-fluorouracil alone versus methotrexate plus 5-fluorouracil for gastric cancer with peritoneal metastasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Metastasis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Gastric Cancer, Neoplasm Metastasis | Phase 3 | Status: COMPLETED